"anti cancer" trang 8 - tải miễn phí từ tailieunhanh
Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
10    62    1
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
10    31    1
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma

N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
20    35    1
Gene expression anti-profiles as a basis for accurate universal cancer signatures

Gene expression anti-profiles as a basis for accurate universal cancer signatures
11    62    1
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: A nationwide matched cohort study

Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: A nationwide matched cohort study
10    18    1
Quercetin enhances vitamin D2 stability and mitigate the degradation influenced by elevated temperature and pH value

Quercetin enhances vitamin D2 stability and mitigate the degradation influenced by elevated temperature and pH value
8    45    1
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    26    1
Genus mallotus (Euphorbiaceae): A review on traditional medicinal use, phytochemistry, and biological activities

Genus mallotus (Euphorbiaceae): A review on traditional medicinal use, phytochemistry, and biological activities
35    24    1
Synthesis and antimicrobial activities of hydrazones derived from 4-hydroxy-3-nitrobenzaldehyde

Synthesis and antimicrobial activities of hydrazones derived from 4-hydroxy-3-nitrobenzaldehyde
9    17    1
Intracranial efficacy and safety of furmonertinib 160mg with or without anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy

Intracranial efficacy and safety of furmonertinib 160mg with or without anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy
11    5    1
Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: A systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: A systematic review and meta-analysis of randomized controlled trials
11    6    1
Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma

Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma
10    1    1
B7-H3 targeted CAR-T cells show highly efcient anti-tumor function against osteosarcoma both in vitro and in vivo

B7-H3 targeted CAR-T cells show highly efcient anti-tumor function against osteosarcoma both in vitro and in vivo
12    1    1
The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma

The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
8    3    1
Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab

Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab
9    8    1
Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients

Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients
9    6    1
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model

CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model
12    56    0
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors
8    92    0
Final results from IMPROVE: A randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer

Final results from IMPROVE: A randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer
12    71    0
AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cell

AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cell
11    60    0